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ScienceDirectThe future sustainable production of chemicals and fuels from
non-petrochemical sources, while at the same time reducing
greenhouse gas (GHG) emissions, represent two of societys
greatest challenges. Microbial chassis able to grow on waste
carbon monoxide (CO) and carbon dioxide (CO2) can provide
solutions to both. Ranging from the anaerobic acetogens,
through the aerobic chemoautotrophs to the photoautotrophic
cyanobacteria, they are able to convert C1 gases into a range of
chemicals and fuels which may be enhanced and extended
through appropriate metabolic engineering. The necessary
improvements will be facilitated by the increasingly
sophisticated gene tools that are beginning to emerge as part
of the Synthetic Biology revolution. These tools, in combination
with more accurate metabolic and genome scale models, will
enable C1 chassis to deliver their full potential.
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Introduction
The continued use of fossil fuels is no longer tenable. A
finite resource, their extraction, processing and exploita-
tion is wreaking havoc with the environment through
pollution and global warming. The challenge facing our
generation is, therefore, to identify sustainable and cleaner
processes for chemical, fuel and energy production. Bio-
logical routes offer the most promising alternative where,
to avoid conflict with the food chain, attention has largely
focussed on using lignocellulosic biomass as the feedstock.
However, its recalcitrance to deconstruction is making the
development of economic processes extremely challeng-
ing. One solution is to directly capture carbon before its
incorporation into lignocellulose through the use of micro-
bial chassis able to utilize single carbon (C1) gases (COCurrent Opinion in Biotechnology 2018, 50:174–181 and CO2) as a feedstock. Such gases are an abundant, low
cost waste product from a wide range of industrial pro-
cesses, with total global carbon emissions from fossil fuel
equivalent to approximately 9.7 gigatons in 2014 [1]. This
includes sources such as steel manufacture and power
generation, additionally the availability of C1 gas from
the anaerobic digestion or gasification of renewable
domestic or agricultural waste and residues provides a
diverse range of feedstocks of C1 gas (Figure 1).
Those C1 fermenting process organisms being most
actively pursued include anaerobic clostridial acetogens,
the aerobic chemolithoautotrophic Cupriavidus necator, var-
ious photoautotrophic cyanobacteria and, in the case of
CH4, the methanotrophic Methylococcus capsulatus. Many
naturally produce metabolites of industrial value, such as
ethanol, butyrate and 2,3-butanediol. The full extent of
their capability, however, resides in their potential to
produce a much wider range of chemicals and fuels through
their rational metabolic engineering. There are many phys-
ical process engineering and commercialisation challenges
that need to be addressed in order to bring this technology
to the wider market, however for the purposes of this short
review we will focus on recent advancements in metabolic
engineering and Synthetic Biology with respect to these
organisms. Additionally we will summarise recent efforts
made with C1 chassis able to grow on CO and CO2; CH4-
utilising bacteria [2] will not be considered, other than to
note current commercial activity (see Table 1).
Acetogens
Obligately anaerobic acetogenic bacteria [3] employ the
Wood–Ljungdahl pathway (WLP) to synthesize acetyl-
CoA from either CO or CO2 + H2 (Figure 2). Acetyl-CoA
can be further directed towards pyruvate, the generation of
biomass, solventogenesis or acetate with, in the latter case,
the generation of ATP. Acetate formation from CO and
CO2, however, does not generate net ATP, as for every
mole of acetate produced one mole of ATP is consumed
during the synthesis of formyl-THF from formate. Rather,
net ATP generation is reliant on the Na+ or proton
gradient (depending on the acetogen), formed by WLP
reducing equivalents, which is coupled to a membrane
bound ATPase [4]. Acetogens are particularly attractive as
chemical production platforms, as the WLP is the most
efficient of the known CO2 fixation pathways.
Native products
Acetogens produce a number of native chemicals and fuels,
including high value C4 compounds such as 2,3-butanediolwww.sciencedirect.com
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Sustainable conversion of waste gases to biofuels and chemicals through a combination of industrial process optimisation and genetic engineering
approaches.(Clostridium ljungdahlii and Clostridium autoethanogenum),
butyrate and butanol (Clostridium carboxidivorans) and 2-
oxobutyrate (Clostridium aceticum and Sporomusa ovata).
Strategies explored to optimise yields include the manipu-
lation of culture conditions, bioreactor design, adaptative
evolution [28–30] and more recently electrosynthesis. The
latter seeks to increase productivity through the direct or
indirect acquisition of electrons. Whilst exciting, the chal-
lenges related to scalability may be unsurmountable [31,32].
Improvements to product yield through metabolic engi-
neering have been made possible by significant improve-
ments in available genetic tools. Exemplification of directed
mutagenesis methods based on intron retargeting and allelic
exchange has allowed insertional disruption, and precise in-
frame deletion, of target genes [8,33]. In C. ljungdahlii, for
example, carbon flow was successfully redirected towards
acetate through in-frame deletions of adhE1 and adhE2 [8].
In contrast, in-frame deletion of aor2 in C. autoethanogenum,
resulted in an approximate 180% increase in ethanol yield
over the wildtype organism [5]. In Acetobacterium woodii
autotrophic acetate formation was improved through over-
expression of WLP genes, resulting in a strain capable of
producing 51 g l1 acetate in 3.8 days [13].
The efficiency of mutant generation by allelic exchange is
improved through the use of CRISPR/cas9 technology aswww.sciencedirect.com it allows the direct selection of the rare mutant alleles that
arise in a population, considerably shortening mutant
isolation time. The successful use of Streptococcus pyro-
genes CRISPR/cas9 in acetogens has been reported. In C.
ljungdahlii, in-frame deletion mutants were generated
within pta, adhE1, ctf and pyrE [34], while knockouts
in 2,3-bdh and adh were successfully made in C. auto-
ethanogenum [35]. It may be anticipated that this type of
system will figure prominently in the future engineering
of acetogens.
Synthetic pathway products
As yet, aside from those claims restricted to patent filings,
examples of product expansion or enhancement through
the incorporation of synthetic pathways in acetogens are
relatively few. Acetone production through overexpres-
sion of the requisite genes (ctfA/B and adc) from Clostrid-
ium acetobutylicum has been reported in C. aceticum [12] and
A. woodii. In the latter case, to concentrations of approxi-
mately 15 mM in batch and 26.4 mg l1 hour1 in contin-
uous culture fermentation [14]. Conversion of acetone to
isopropanol as a consequence of a native alcohol dehy-
drogenase (CaADH) has been demonstrated in C. auto-
ethanogenum during both heterotrophic [36] and autotro-
phic [6] growth. Autotrophic production of isopropanol
has similarly been achieved in C. ljungdahlii [11].Current Opinion in Biotechnology 2018, 50:174–181
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Table 1
Examples of targeted metabolic efforts towards selected platform chemicals and biofuels within most prominent C1 chassis of the four
groupings
C1 chassis Engineering target product Native/recombinant
product
Largest production
scale
Example
studies/companies
Major acetogens
Clostridium autoethanogenum Ethanol Native Industrial (15 000 l) Lanzatech [5]
2,3-Butanediol Native Demonstration Lanzatech
Acetone/isopropanol Recombinant Proprietary Lanzatech [6]
Butanol Recombinant Proprietary Lanzatech [7]
Clostridium ljungdahlii Acetate Native Laboratory [8]
Butyrate Recombinant Laboratory [9]
Butanol Recombinant Laboratory [10]
Isopropanol Recombinant Laboratory [11]
Clostridium aceticum Acetone Recombinant Laboratory [12]
Acetobacterium woodii Acetate Native Laboratory [13]
Acetone Recombinant Laboratory [14]
Chemoautotroph
Cupriavidus necator PHB Native Laboratory [15]
Alka(e)nes Recombinant Laboratory [16]
3HP Recombinant Laboratory [17]
Isopropanol Recombinant Laboratory [18,19]
Isobutanol/methy-1-butanol Recombinant Laboratory [20]
Photoautotroph
Synechococcus elongatus UTEX 2973 Ethanol Recombinant Laboratory [21]
1-Butanol/isobutanol Recombinant Laboratory [22]
Synechococcus elongatus PCC 7942 Succinate Recombinant Laboratory [23]
Synechocystis sp. PCC 6803 Ethylene Recombinant Laboratory [24]
Methanotroph
Methylotrophus capsulatus Propylene Recombinant Undisclosed Calysta [25]
Undisclosed methanotrophic species Isobutanol Recombinant Pilot plant Intrexon [26]
Farnesene Recombinant Undisclosed Intrexon [27]Whilst C. carboxidivorans naturally produces butyrate and
butanol, their production in C. autoethanogenum [7] and C.
ljungdahlii [10] has been demonstrated using plasmid-
located genes (Figure 2) derived from C.
acetobutylicum. In the latter case, to concentrations of
approximately 2 mM at exponential phase growth in batch
fermentation [10]. More recently butyrate production in
C. ljungdahlii from CO/CO2 was increased to 16 mM
through genome integration of the butyrate pathway
genes (Figure 2) concomitant with deletion of pta and
adhE1 [9]. Whilst further deletions were acknowledged as
likely to result in higher butyrate yields, the inefficient
tools available at the time precluded their generation.
The advent of CRISPR/cas9 systems has the potential to
overcome these limitations.
Cupriavidus necator
A number of autotrophic bacteria use oxygen as the
electron acceptor during CO2 fixation through a reductive
pentose phosphate cycle. By far the most studied and
developed aerobic chassis of this type is C. necator, for-
merly Ralstonia eutropha. A facultative chemolithoauto-
troph, it is able to grow heterotrophically on a range of
organic carbon sources, in addition to its use of CO2, H2
and O2 as sole carbon and energy sources. A broad genetic
toolkit is available that allows rudimentary genomeCurrent Opinion in Biotechnology 2018, 50:174–181 editing as well as the controlled expression of heterolo-
gous genes from a subset of vectors [37] (Figure 3).
Native products
Under nutrient limitation, C. necator directs the majority
of its reduced carbon into synthesis of the biopolymer
poly[(R)-3-hydroxybutyrate] (PHB), an energy and car-
bon storage compound that can accumulate at rates of up
to 1.55 g l1 hour1, eventually representing some 70% of
total cell weight [38]. PHB is formed from acetyl-CoA
through the sequential activities of 3-ketothiolase (PhaA),
acetoacetyl reductase (PhaB) and PHA synthase (PhaC).
The practical industrial applications of PHB are as a
bioplastic, however, derivatives may have more wide
ranging applications in medical and pharmaceutical fields
[39]. The existing high levels of production have limited
the scope for substantive increases through metabolic
engineering. Indeed, the plasmid-based overexpression
of the native phaCAB operon actually reduced productiv-
ity [15].
Synthetic pathway products
The ability of C. necator to divert so much of its carbon
into PHB makes it an attractive chassis for chemical and
fuel production, based on the assumption that other, more
desirable products could replace PHB as the carbon sink.www.sciencedirect.com
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The Wood–Ljungdahl pathway of acetogens with possible products (boxed). ACK, acetate kinase; ACS, CO dehydrogenase/acetyl-CoA synthase;
ADC, acetone decarboxylase; ADHE, aldehyde/alcohol dehydrogenase; ALDC, acetolactate decarboxylase; ALS, acetolactate synthase; AOR,
aldehyde:ferredoxin oxidoreductase; BCD, butyryl-CoA dehydrogogenase; CoFeS-P, corrinoid iron–sulphur protein; CRT, crotonase; CTFA/B,
acetoacetyl-CoA:acetate/butyrate-CoA-transferase; FAK, fatty acid kinase; Fd, oxidized ferredoxin; Fd 2, reduced ferredoxin; FDH, formate
dehydrogenase; FTS, formyl-THF synthetase; HBD, 3-hydroxybutyryl-CoA dehydrogenase; LDH, lactate dehydrogenase; MTI, methyltransferase I;
MTII, methyltransferase II; MTC, methenyl-THF cyclohydrolase; MTD, methylene-THF dehydrogenase; MTF, methyltransferase; MTR, methylene-
THF reductase; PFOR, pyruvate:ferredoxin oxidoreductase; PTA, phosphotransacetylase; PTF, phosphotransferase; RNF, Rnf complex THF:
tetrahydrofolate; THL, thiolase, 2,3-BDH: 2,3-butanediol dehydrogenase; 2 [H], reducing equivalents (e.g. NADH or NADPH). Figure adapted from
Bengelsdorf FR, Straub M, Durre P: Bacterial synthesis gas (syngas) fermentation. Environ Technol 2013, 34:1639–651.Accordingly, isopropanol production at up to final con-
centrations of 3.44 g l1 have been achieved in heterotro-
phic batch conditions by overexpressing codon optimised
clostridial genes (Figure 2) in a phaB/phaC double mutant
[18]. The observed slow growth rates were subsequently
alleviated by overexpression of native GroESL genes
leading to final isopropanol concentrations of 9.8 g l1
in fed batch cultures using fructose as carbon source.
During auxotrophic growth, isopropanol reached final
concentrations of 250 mg l1 in only 12 hours [19].
Recombinant fructose grown strains producing appreci-
able titres of isobutanol (270 mg l1) and of 3-methyl-1-
butanol (40 mg l1) have also been engineered through
heterologous overexpression of ketoisovaleratewww.sciencedirect.com decarboxylase and alcohol dehydrogenase encoding
genes from Lactococcus lactis and Escherichia coli, respec-
tively, in combination with the disruption of competing
pathways. These included deletion of the phaCAB
operon, and the circumvention of three potential carbon
sinks through deletion of ilvE, bkdAB and
aceE. Additionally, the native branched-chain amino acid
biosynthesis pathway genes, which generate the precur-
sors to the introduced synthetic pathway, were
overexpressed.
Alkanes and alkenes are the predominant components of
diesel, petrol and jet fuel, and are therefore attractive
biofuel targets. Heterologous expression of an alkane
synthesis pathway from Synechococcus elongatus, comprisingCurrent Opinion in Biotechnology 2018, 50:174–181
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NADH
Simplified overview of autotrophic native poly-3-hydroxybutyrate and recombinant acetone/isopropanol production pathways in Cupriavidus
necator. Abbreviations: 3-PGA (3-phosphoglyceric acid), G3P (glyceraldehyde-3-phosphate), RuBP (ribulose bisphosphate), GP (glycerate-3-
phosphate), CoA (coenzyme a), TCA (tricarboxylic acid), ATP (adenosine triphosphate), ADP (adenosine diphosphate), NAD (nicotinamide adenine
dinucleotide). Native enzymes; PHAA (acetyl-CoA acetyltransferase), PHAB (acetoacetyl-CoA reductase), PHAC (polyhydroxyalkanoic acid
synthase), CTF (acetoacetyl-CoA transferase). Recombinant enzymes; ADC (Acetoacetate decarboxylase), ADH (alcohol dehydrogenase).genes encoding an acyl-ACP reductase and an aldehyde
deformylating oxygenase, autotrophic alkane production
was demonstrated in C. necator. Through knockout medi-
ated redirection of carbon flow from PHA synthesis,
435 mg l1 of alka(e)nes and 670 mg l1 total hydrocar-
bons were achieved in batch growth on heterotrophic
carbon sources, while on gas (H2/O2/CO2 composition
of 60:2:10) a final concentration of 4.4 mg l1 was
achieved. The latter represents the first demonstration
of non-native alka(e)ne production from C1 gas [16].
Cyanobacteria
Cyanobacteria are a diverse group of photosynthetic
organisms capable of growth using sunlight and CO2 as
their source of energy and carbon, respectively. Cyano-
bacteria more suited to biotechnical applications then
other photosynthetic organisms due to their compara-
tively rapid growth rate and well-developed genetic tools.
The major challenges for the implementation of a pho-
toautotrophic microbial platform for fuel and chemical
production is how to supply dense cultures with sufficient
sunlight to support fermentation at scale. Nevertheless,Current Opinion in Biotechnology 2018, 50:174–181 they remain an exciting microbial chassis, capable of
producing industrially relevant chemicals and fuels at
high titres.
Native products
Cyanobacteria have a broad spectrum of natively pro-
duced secondary metabolites, including amino acids, fatty
acids, macrolides, lipopeptides and amides [40], some of
which have potential pharmaceutical applications. Strat-
egies to improve production of native compounds have
largely focussed on either increasing the efficiency of
photosynthesis, through overexpression of the carbon
fixing enzyme RuBisCO, or reducing the light harvesting
capabilities of the organism to avoid the issue of excess
light absorption above the optimal values. The latter is to
allow deeper light penetration into high optical density
cultures [41]. Genome editing through homologous
recombination and suicide plasmids has been established
in the most developed strains, predominantly Synechocystis
and Synechococcus. Additionally the Streptococcus pyogenes
CRISPR/Cas9 system has recently been exemplified in
S. elongatus UTEX 2973 through in-frame deletion of thewww.sciencedirect.com
Chemicals from C1 gas Humphreys and Minton 179nblA gene [42]. NblA is involved in the degradation of
phycobilisomes; primary antenna protein complexes asso-
ciated with photosystem II.
Synthetic pathway products
The production of a wide range of biofuels and industri-
ally relevant chemicals has been demonstrated through
expression of heterologous genes within cyanobacteria,
including ethanol [21], 1-butanol, isobutanol [21] and
ethylene [24] to name a few. Recently a CRISPR-
Cas9-assisted simultaneous glgc knockout and gltA/ppc
knockin for succinate production was demonstrated in
S. elongatus PCC 7942 [23], paving the way for the rapid
generation of further stable strains where the overex-
pressed genes are localised to the chromosome.
Metabolic and genome scale modelling
As our capability to genetically modify the range of C1
chassis available becomes more effective, so must our
ability to identify the most rational gene targets for
modification. The generation of sophisticated metabolic
and genome scale models, in combination with the col-
lection of proteomic and metabolomic datasets, is increas-
ingly allowing in silico engineering studies to elucidate
exciting, and often un-intuitive, potential targets for
manipulation within industrially relevant organisms.
Chen and co-workers recently published a list of proposed
targets for deletion and overexpression in C. ljungdahlii to
increase the productivity of native and non-native pro-
ducts, using a genome-scale metabolic reconstruction of
the organisms’ metabolism [43]. In parallel, a study by
Richter et al. proposed a different model for product
regulation, based predominantly on thermodynamics,
nutrient limitation and pH manipulation, rather than
genetic regulation [44]. Numerous metabolic models
have been proposed for C. necator [45–47], with Park and
co-workers proposing the first genome scale model capa-
ble of in silico engineering and culture condition strategies
towards enhanced 2-methylcitric acid production, as well
as enhanced PHA and PHB production [45].
Conclusions
Progress towards the development of C1 fermenting
microorganisms as chassis for the production of chemicals
and fuels is gathering pace as available Synthetic Biology
tools and genome scale models become ever more sophis-
ticated. As novel technologies such as CRISPR/cas9
mutagenesis are implemented across the broad range of
chassis, we can expect to see a rapid increase in the rate of
generation of central metabolic pathway mutants, and
elucidation of the intricacies of the pathways. Heterolo-
gous expression systems will continue to be developed
and modularised, with stable expression of pathways from
the chromosome rather than plasmid being a logical step
to expect from the developing chassis organisms, increas-
ing industrial applications. Significantly progress is being
made on all fronts with the leading chassis, but presentlywww.sciencedirect.com the most commercially advanced system is the ethanol
production process being pursued by LanzaTech based
on the anaerobic acetogen C. autoethanogenum and the use
of steel mill off-gas. Full scale production plants are
planned or under construction at steel mills in China,
Taiwan and Belgium. The production of other products at
a commercial scale appears to be planned for an undeter-
mined time in the future and are likely to be confined to
reduced products whose synthesis requires minimal input
of ATP in keeping with the anaerobic nature of this
chassis. Those products that need significant ATP will
require the use of an aerobic chassis, such as Cupriavidus
or Cyanobacteria. In both cases, scale remains an issue.
The former because of the more challenging issues of
using an explosive gas mixture that combines O2 with H2
and CO2, while the latter will always be compromised by
the difficulties of providing sufficient light input at scale.
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